Althera Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALTHERA PHARMS, and what generic alternatives to ALTHERA PHARMS drugs are available?
ALTHERA PHARMS has two approved drugs.
There are two US patents protecting ALTHERA PHARMS drugs.
There are seven patent family members on ALTHERA PHARMS drugs in ten countries and fourteen supplementary protection certificates in eight countries.
Drugs and US Patents for Althera Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Althera Pharms | ROSZET | ezetimibe; rosuvastatin calcium | TABLET;ORAL | 213072-002 | Mar 23, 2021 | DISCN | Yes | No | 10,376,470 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Althera Pharms | ROSZET | ezetimibe; rosuvastatin calcium | TABLET;ORAL | 213072-003 | Mar 23, 2021 | DISCN | Yes | No | 9,763,885 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Althera Pharms | ROSZET | ezetimibe; rosuvastatin calcium | TABLET;ORAL | 213072-001 | Mar 23, 2021 | DISCN | Yes | No | 9,763,885 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Althera Pharms | LYPQOZET | atorvastatin calcium; ezetimibe | TABLET;ORAL | 206084-002 | Apr 26, 2017 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Althera Pharms | LYPQOZET | atorvastatin calcium; ezetimibe | TABLET;ORAL | 206084-004 | Apr 26, 2017 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Althera Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 2014013241 | ⤷ Sign Up |
Poland | 2844233 | ⤷ Sign Up |
Spain | 2802252 | ⤷ Sign Up |
Denmark | 2844233 | ⤷ Sign Up |
Portugal | 2844233 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Althera Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1003503 | 30/2006 | Austria | ⤷ Sign Up | PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN; NAT. REGISTRATION NO/DATE: 1-26271, 1-26273 20060330; FIRST REGISTRATION: FR 369300.9;369301.5; 369302.1;369303.8;369304.4;369305.0; 20050707 |
0720599 | 05C0040 | France | ⤷ Sign Up | PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402 |
1003503 | 05C0048 | France | ⤷ Sign Up | PRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707 |
0247633 | 97C0118 | France | ⤷ Sign Up | PRODUCT NAME: ATORVASTATINE CALCIQUE TRIHYDRATE; REGISTRATION NO/DATE IN FRANCE: NL 21960 DU 19970321; REGISTRATION NO/DATE AT EEC: PL 00018/0240 DU 19961107 |
0247633 | 62/1997 | Austria | ⤷ Sign Up | PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.